Fabrizio Salomone Selected Research

poractant alfa (Curosurf)

6/2022	Efficacy of synthetic surfactant (CHF5633) bolus and/or lavage in meconium-induced lung injury in ventilated newborn rabbits.
1/2020	In vitro characterization and in vivo comparison of the pulmonary outcomes of Poractant alfa and Calsurf in ventilated preterm rabbits.
1/2020	Nebulized Poractant Alfa Reduces the Risk of Respiratory Failure at 72 Hours in Spontaneously Breathing Surfactant-Deficient Newborn Piglets.
1/2020	Dose-Response Study on Surfactant Nebulization Therapy During Nasal Continuous Positive Airway Pressure Ventilation in Spontaneously Breathing Surfactant-Deficient Newborn Piglets.
12/2017	In vitro and in vivo characterization of poractant alfa supplemented with budesonide for safe and effective intratracheal administration.
1/2017	In Vivo Evaluation of the Acute Pulmonary Response to Poractant Alfa and Bovactant Treatments in Lung-Lavaged Adult Rabbits and in Preterm Lambs with Respiratory Distress Syndrome.
1/2017	Cerebral and lung effects of a new generation synthetic surfactant with SP-B and SP-C analogs in preterm lambs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fabrizio Salomone Research Topics

Disease

10	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 05/2022 - 01/2017
9	Lung Injury 06/2022 - 01/2018
6	Newborn Respiratory Distress Syndrome 06/2022 - 01/2017
6	Inflammation (Inflammations) 07/2021 - 01/2019
6	Bronchopulmonary Dysplasia 06/2021 - 12/2017
5	Hyperoxia 12/2020 - 01/2018
4	Pneumonia (Pneumonitis) 06/2022 - 12/2017
2	Meconium Aspiration Syndrome 06/2022 - 01/2020
2	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2022 - 07/2021
2	Respiratory Insufficiency (Respiratory Failure) 01/2020 - 01/2018
2	Brain Injuries (Brain Injury) 01/2019 - 01/2017
2	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2018 - 12/2017
1	Diseases Newborn Infant 01/2022
1	Asthma (Bronchial Asthma) 07/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 07/2021
1	Allergic Rhinitis 07/2021
1	Chorioamnionitis 01/2021
1	Body Weight (Weight, Body) 10/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Acute-Phase Reaction 01/2018
1	Pain (Aches) 12/2017
1	Fever (Fevers) 12/2017
1	Hemorrhage 12/2017
1	Neoplasms (Cancer) 12/2013
1	Diabetes Mellitus 12/2012
1	Alzheimer Disease (Alzheimer's Disease) 12/2012

Drug/Important Bio-Agent (IBA)

21	Surface-Active Agents (Surfactants)IBA 06/2022 - 01/2017
9	Budesonide (Pulmicort)FDA LinkGeneric 07/2021 - 12/2017
7	poractant alfa (Curosurf)FDA Link 06/2022 - 01/2017
4	CHF5633IBA 06/2022 - 01/2017
3	CytokinesIBA 06/2022 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2017
2	Messenger RNA (mRNA)IBA 06/2022 - 01/2020
2	Phospholipids (Phosphatides)FDA LinkGeneric 06/2022 - 01/2020
2	Pulmonary Surfactants (Pulmonary Surfactant)IBA 07/2019 - 01/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2021
1	Therapeutic UsesIBA 07/2021
1	Small Interfering RNA (siRNA)IBA 01/2020
1	AntagomirsIBA 01/2020
1	calsurfIBA 01/2020
1	Ibuprofen (Motrin)FDA LinkGeneric 01/2018
1	Oxygen (Dioxygen)IBA 01/2018
1	Caffeine (No Doz)FDA LinkGeneric 01/2018
1	HydrogelsIBA 01/2018
1	KetorolacIBA 01/2018
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2017
1	Acetaminophen (Paracetamol)FDA LinkGeneric 12/2017
1	EicosanoidsIBA 12/2017
1	Peptides (Polypeptides)IBA 01/2017
1	VitronectinIBA 12/2013
1	PropaneIBA 12/2013
1	LipidsIBA 12/2013
1	IntegrinsIBA 12/2013
1	DNA (Deoxyribonucleic Acid)IBA 12/2013
1	1,2- dioleoyloxy- 3- (trimethylammonium)propaneIBA 12/2013
1	CopperIBA 12/2012
1	AluminumIBA 12/2012
1	Trace Elements (Biometals)IBA 12/2012
1	ZincIBA 12/2012

Therapy/Procedure

6	Artificial Respiration (Mechanical Ventilation) 01/2021 - 01/2018
4	Continuous Positive Airway Pressure 01/2020 - 01/2017
3	Therapeutics 01/2022 - 01/2018
2	Nebulizers and Vaporizers (Inhaler) 01/2020 - 01/2020
1	Cannula 05/2022
1	Aftercare (After-Treatment) 01/2020
1	Mechanical Ventilators (Ventilator) 01/2020
1	Cesarean Section (Caesarean Section) 01/2020
1	Injections 01/2019
1	Intermittent Positive-Pressure Ventilation 01/2018